GlassScriptPhysician profile
Lauren Johnson
NPI 1184117434
$243.01
in general payments reported to CMS, 2019-2025
9 companies · $57.32 in 2025
The $57.32 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.16 · 2023: $47.48 · 2024: $94.05 · 2025: $57.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $66.91 | 2023-2024 | |
| Tersera Therapeutics LLC | $38.28 | 2025 | Zoladex |
| Genentech USA, INC. | $28.26 | 2021 | |
| Optinose US, INC. | $22.95 | 2024 | |
| Argenx US, INC. | $20.73 | 2024 | Vyvgart Hytrulo, Vyvgart |
| Novo Nordisk INC | $19.04 | 2025 | Ozempic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.39 | 2024 | Xifaxan |
| Dexcom, INC. | $15.90 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.55 | 2023 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.